A widely used painkiller is meant to be taken for five days or fewer
In short: Ketorolac is a strong painkiller that works by blocking enzymes which produce pain-linked prostaglandins. Its use is generally capped at about five days, because longer treatment raises the risk of serious harm, especially to the kidneys. Here is how it works, why it is carefully limited, and why its history is more complicated than its everyday reputation suggests.
Ketorolac belongs to the nonsteroidal anti-inflammatory drugs, known as NSAIDs. Clinicians prescribe it for brief bouts of moderate to severe pain, and it can be given orally, through the nasal passage, by injection into a vein or muscle, or as eye drops. Relief tends to begin within about an hour and can last up to eight hours. The drug also lowers fever. Its patent dates to 1976, and it entered medical practice in 1989; generic versions are now sold. In 2023 it ranked 228th among the most frequently prescribed medicines in the country, with prescriptions numbering in the millions.
The mechanism is straightforward. Ketorolac blocks two enzymes, cyclooxygenase 1 and 2, which lowers the body's output of prostaglandins. These compounds carry signals that tighten or relax smooth muscle and drive inflammation, so reducing them eases both pain and swelling. Because the drug inhibits both enzymes without distinction, it is classed as a first-generation NSAID, a category linked to stomach complications. Later NSAIDs were designed to target the second enzyme more selectively in an effort to avoid those problems. The same blocking action also weakens the kidney's own protective responses during events such as blood loss, which is one reason kidney risk is taken so seriously.
The safety record explains why limits matter. Serious though uncommon effects can include stomach bleeding, kidney failure, heart attacks and severe allergic reactions. Germany withdrew ketorolac as a pain treatment in 1993 after a run of deaths from gastrointestinal bleeding and kidney failure, even though doctors there had been using it as a stand-in for opioids. Mounting reports of side effects led several countries to restrict doses and treatment length, and between 1990 and 1993, 97 fatal reactions were reported worldwide. One assessment rates ketorolac as a relatively higher-risk NSAID compared with aceclofenac, celecoxib and ibuprofen.
Ketorolac also has accepted specialist roles. Paired with paracetamol, it can relieve pain in newborns without suppressing breathing the way opioids can, and it boosts relief when combined with opioid medication. As eye drops it helps manage discomfort during eye surgery and itching of the eye. Its place in professional sport is more contested. It is reported to be used routinely in American football and ice hockey leagues, and a 2017 lawsuit by former players alleged widespread painkiller use sanctioned by the league. More recent research suggests that urging injured athletes to keep playing tends to produce more severe injuries.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Ketorolac
To cite this card, link to https://intellectplus.co.uk/app/health-ketorolac.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Morbidity · More in Health · Latest · A–Z · All topics